go - Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least 3 years, in return for the U.K. spending more on new medicines
AI Summary: In a twist worthy of a Hollywood trade drama, officials announced that the UK and US have struck a deal to impose zero tariffs on UK‐made medicines destined for the US. As part of the arrangement, the UK must shell out considerably more for drug pricing—a move set to avoid tariffs that could soar as high as 100%—with the agreement effective for at least three years.
CVS sues Tennessee over PBM‑pharmacy separation law / 4 days
AbbVie sues over Botox selection in Medicare price negotiations / 3 months
HHS drops 340B pilot following court rulings / 3 months
HHS scraps 340B rebate pilot following court rulls / 3 months
FTC settles insulin lawsuit forces Express Scripts policy changes / 3 months
Judge blocks 340B drug pricing pilot program implementation / 4 months
CMS Unveils Medicaid Drug Pricing Model with Most-Favored Nation Approach / 6 months
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.